Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia

Neurol Sci. 2014 Sep;35(9):1485-6. doi: 10.1007/s10072-014-1800-y. Epub 2014 Apr 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Female
  • Fingolimod Hydrochloride
  • Gadolinium
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Lymphopenia / chemically induced*
  • Magnetic Resonance Imaging
  • Multiple Sclerosis, Relapsing-Remitting / complications
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Propylene Glycols / adverse effects*
  • Sphingosine / adverse effects
  • Sphingosine / analogs & derivatives*

Substances

  • Immunosuppressive Agents
  • Propylene Glycols
  • Gadolinium
  • Fingolimod Hydrochloride
  • Sphingosine